HUP0400504A2 - Kombinált 5-HT1A-agonisták és szelektív szerotonin-újrafelvétel inhibitorok új alkalmazása - Google Patents
Kombinált 5-HT1A-agonisták és szelektív szerotonin-újrafelvétel inhibitorok új alkalmazásaInfo
- Publication number
- HUP0400504A2 HUP0400504A2 HU0400504A HUP0400504A HUP0400504A2 HU P0400504 A2 HUP0400504 A2 HU P0400504A2 HU 0400504 A HU0400504 A HU 0400504A HU P0400504 A HUP0400504 A HU P0400504A HU P0400504 A2 HUP0400504 A2 HU P0400504A2
- Authority
- HU
- Hungary
- Prior art keywords
- selective serotonin
- combined
- serotonin reuptake
- reuptake inhibitors
- novel use
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 title 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
- 208000002193 Pain Diseases 0.000 abstract 3
- 208000004454 Hyperalgesia Diseases 0.000 abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 abstract 1
- 208000035154 Hyperesthesia Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 206010053552 allodynia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000008058 pain sensation Effects 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- SGEGOXDYSFKCPT-UHFFFAOYSA-N vilazodone Chemical compound C1=C(C#N)C=C2C(CCCCN3CCN(CC3)C=3C=C4C=C(OC4=CC=3)C(=O)N)=CNC2=C1 SGEGOXDYSFKCPT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgyát képezi kombinált szelektív szerotonin (5-HT)újrafelvétel inhibitor (SSRI) és 5-HT1A-receptor agonista vegyületek,különösen az 1-[4-(5-cianoindol-3-il)butil]-4-(2-karbamoil-benzofurán-5-il)-piperazin vagy annak egy fiziológiásan elfogadható sója, vagy a3-{4-[4-(4-ciano-fenil)-piperazin-l-il]-butil}-1H-indol-5-karbonitrilvagy annak egy fiziológiásan elfogadható sója alkalmazása olyangyógyszerek előállítására, amelyek alkalmazhatók krónikus fájdalom,betegségek vagy más olyan állapotok kezelésére, amelyekbenhiperszenzitizáció alakul ki a fájdalomszignálokkal szemben,hiperalgézia, allodínía, fokozott fájdalomérzet és fokozottfájdalommemória jelentkezik, továbbá irritábilis bélszindróma (IBS)kezelésére. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00125409 | 2000-11-20 | ||
PCT/EP2001/012686 WO2002039989A1 (en) | 2000-11-20 | 2001-11-02 | Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0400504A2 true HUP0400504A2 (hu) | 2004-06-28 |
HUP0400504A3 HUP0400504A3 (en) | 2006-02-28 |
Family
ID=8170432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0400504A HUP0400504A3 (en) | 2000-11-20 | 2001-11-02 | Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors |
Country Status (19)
Country | Link |
---|---|
US (1) | US7479492B2 (hu) |
EP (1) | EP1335716A1 (hu) |
JP (1) | JP2004513916A (hu) |
KR (1) | KR20030048477A (hu) |
CN (1) | CN1541093A (hu) |
AR (1) | AR031463A1 (hu) |
AU (2) | AU2180302A (hu) |
BR (1) | BR0115434A (hu) |
CA (1) | CA2429216C (hu) |
CZ (1) | CZ20031448A3 (hu) |
HU (1) | HUP0400504A3 (hu) |
MX (1) | MXPA03004341A (hu) |
NO (1) | NO20032248D0 (hu) |
PL (1) | PL361617A1 (hu) |
RU (1) | RU2302243C2 (hu) |
SK (1) | SK6442003A3 (hu) |
UA (1) | UA76130C2 (hu) |
WO (1) | WO2002039989A1 (hu) |
ZA (1) | ZA200304757B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10326939A1 (de) * | 2003-06-16 | 2005-01-05 | Merck Patent Gmbh | Indol-Derivate |
WO2005094896A2 (en) * | 2004-03-26 | 2005-10-13 | Baylor University | Targeted serotonin reuptake inhibitors |
WO2006006152A2 (en) * | 2004-07-08 | 2006-01-19 | Ramot At Tel-Aviv University Ltd | Treatment of disorders and diseases of the colon |
US7994331B2 (en) | 2005-07-13 | 2011-08-09 | Msd K.K. | Heterocycle-substituted benzimidazole derivative |
PL2044043T5 (pl) | 2006-06-16 | 2022-05-02 | H. Lundbeck A/S | Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych |
TW200848411A (en) * | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2222768B (en) | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
US5589511A (en) * | 1990-08-13 | 1996-12-31 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
US5578612A (en) | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
US5434174A (en) | 1992-07-17 | 1995-07-18 | Eli Lilly And Company | Isoxazole derivatives for the treatment of irritable bowel syndrome |
DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
UA56185C2 (uk) | 1996-09-30 | 2003-05-15 | Пфайзер Інк. | Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування |
GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
TW518218B (en) * | 1999-05-27 | 2003-01-21 | Merck Patent Gmbh | Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders |
-
2001
- 2001-02-11 UA UA2003065609A patent/UA76130C2/uk unknown
- 2001-11-02 HU HU0400504A patent/HUP0400504A3/hu unknown
- 2001-11-02 SK SK644-2003A patent/SK6442003A3/sk not_active Application Discontinuation
- 2001-11-02 PL PL36161701A patent/PL361617A1/xx not_active Application Discontinuation
- 2001-11-02 AU AU2180302A patent/AU2180302A/xx active Pending
- 2001-11-02 JP JP2002542364A patent/JP2004513916A/ja active Pending
- 2001-11-02 CA CA2429216A patent/CA2429216C/en not_active Expired - Fee Related
- 2001-11-02 EP EP01996368A patent/EP1335716A1/en not_active Ceased
- 2001-11-02 BR BR0115434-6A patent/BR0115434A/pt not_active Application Discontinuation
- 2001-11-02 MX MXPA03004341A patent/MXPA03004341A/es active IP Right Grant
- 2001-11-02 US US10/432,047 patent/US7479492B2/en not_active Expired - Lifetime
- 2001-11-02 AU AU2002221803A patent/AU2002221803B2/en not_active Ceased
- 2001-11-02 KR KR10-2003-7006755A patent/KR20030048477A/ko not_active Application Discontinuation
- 2001-11-02 RU RU2003116893/15A patent/RU2302243C2/ru not_active IP Right Cessation
- 2001-11-02 WO PCT/EP2001/012686 patent/WO2002039989A1/en not_active Application Discontinuation
- 2001-11-02 CZ CZ20031448A patent/CZ20031448A3/cs unknown
- 2001-11-02 CN CNA018191118A patent/CN1541093A/zh active Pending
- 2001-11-16 AR ARP010105360A patent/AR031463A1/es unknown
-
2003
- 2003-05-19 NO NO20032248A patent/NO20032248D0/no unknown
- 2003-06-19 ZA ZA200304757A patent/ZA200304757B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20032248L (no) | 2003-05-19 |
ZA200304757B (en) | 2004-09-20 |
RU2302243C2 (ru) | 2007-07-10 |
CA2429216A1 (en) | 2002-05-23 |
US7479492B2 (en) | 2009-01-20 |
AU2002221803B2 (en) | 2007-02-15 |
CA2429216C (en) | 2012-08-07 |
CN1541093A (zh) | 2004-10-27 |
NO20032248D0 (no) | 2003-05-19 |
JP2004513916A (ja) | 2004-05-13 |
UA76130C2 (en) | 2006-07-17 |
MXPA03004341A (es) | 2003-08-19 |
HUP0400504A3 (en) | 2006-02-28 |
CZ20031448A3 (cs) | 2003-09-17 |
BR0115434A (pt) | 2003-10-07 |
EP1335716A1 (en) | 2003-08-20 |
US20040014771A1 (en) | 2004-01-22 |
AR031463A1 (es) | 2003-09-24 |
KR20030048477A (ko) | 2003-06-19 |
SK6442003A3 (en) | 2003-09-11 |
WO2002039989A1 (en) | 2002-05-23 |
PL361617A1 (en) | 2004-10-04 |
AU2180302A (en) | 2002-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
UA87456C2 (uk) | Циклічні інгібітори протеїнтирозинкіназ | |
ATE371656T1 (de) | Heteroaryl-pyrimidinderivate als jak-inhibitoren | |
DK1620082T3 (da) | Medicinsk anvendelse af inhibitorer af glutaminyl- og glutamatcyclaser til behandling af Alzheimers sygdom og Downs syndrom | |
NO20076635L (no) | Krystallinske og andre former for 4-amino-5-fluor-3-[6-(4-metylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-kinolin-2-on-melkesyresalter | |
MY137480A (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
MX2010006238A (es) | Formulaciones del acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5 -il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoico. | |
DK1299382T3 (da) | Præparat og antiviral virkning af substituerede indoloxoeddikesyrepiperazinderivater | |
NO20061396L (no) | Nye heterocykliske forbindelser som HSP90-inhibitorer | |
NO20050514L (no) | Sammensetning og antiviral aktivitet til substituerte azaindoloksoeddikpiperazinderivater | |
EA200901514A1 (ru) | Новая сольватная и кристаллическая форма производных карбамоилциклогексана | |
ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
MX2021002111A (es) | Sales de adición de ácido de succinato y fumarato de derivados de piperazina útiles como inhibidores de glucosidasa. | |
DE69725345D1 (de) | Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden | |
NO20050270L (no) | Nye forbindelser, deres anvendelse og fremstilling | |
HUP0400504A2 (hu) | Kombinált 5-HT1A-agonisták és szelektív szerotonin-újrafelvétel inhibitorok új alkalmazása | |
NO20065835L (no) | Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander | |
MA33120B1 (fr) | Procede ou systeme utilisant des biomarqueurs pour la surveillance d'un traitement | |
HUP0100082A2 (hu) | Trombininhibitor hatású peptidszármazékok, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0302751A2 (hu) | Kombinált 5-HT1A receptor agonista és szerotonin újrafelvételt gátló hatású vegyületek új alkalmazásai | |
RU2003115431A (ru) | Новые применения объединенных агонистов 5-нт1а и ингибиторов обратного захвата серотонина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |